ATE353645T1 - Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia - Google Patents
Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesiaInfo
- Publication number
- ATE353645T1 ATE353645T1 AT02774687T AT02774687T ATE353645T1 AT E353645 T1 ATE353645 T1 AT E353645T1 AT 02774687 T AT02774687 T AT 02774687T AT 02774687 T AT02774687 T AT 02774687T AT E353645 T1 ATE353645 T1 AT E353645T1
- Authority
- AT
- Austria
- Prior art keywords
- oxo
- dyskinesia
- producing
- treatment
- pyrrolidine derivatives
- Prior art date
Links
- 208000012661 Dyskinesia Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 abstract 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000009256 replacement therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01123976 | 2001-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE353645T1 true ATE353645T1 (de) | 2007-03-15 |
Family
ID=8178883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02774687T ATE353645T1 (de) | 2001-10-08 | 2002-10-07 | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20040242671A1 (de) |
| EP (1) | EP1435943B1 (de) |
| JP (1) | JP4351909B2 (de) |
| AT (1) | ATE353645T1 (de) |
| AU (1) | AU2002340971B2 (de) |
| CA (1) | CA2461961A1 (de) |
| DE (1) | DE60218193T2 (de) |
| ES (1) | ES2281545T3 (de) |
| HU (1) | HUP0401667A2 (de) |
| MX (1) | MXPA04002714A (de) |
| PL (1) | PL370529A1 (de) |
| WO (1) | WO2003030899A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004071449A2 (en) | 2003-02-12 | 2004-08-26 | Bristol-Myers Squibb Company | Lactams as modulators of chemokine receptor activity |
| WO2008095221A1 (en) | 2007-02-07 | 2008-08-14 | Gosforth Centre (Holdings) Pty Ltd | Treatment of adhd |
| US20110212944A1 (en) * | 2008-07-01 | 2011-09-01 | Julie Liu | 2-oxo-1-pyrrolidine derivatives |
| JP2011529923A (ja) | 2008-08-06 | 2011-12-15 | ゴスフォース センター（ホールディングス）プロプライエタリー リミテッド | 精神障害（ｐｓｙｃｈｉａｔｒｉｃｄｉｓｏｒｄｅｒ）を治療するための組成物および方法 |
| WO2012027825A1 (en) * | 2010-08-31 | 2012-03-08 | Mcmaster University | Method of treating dopamine-related neuropsychiatric disorders |
| HUE049827T2 (hu) | 2013-12-03 | 2020-10-28 | Fmc Corp | Pirrolidinonok mint herbicidek |
| US11589583B2 (en) | 2013-12-03 | 2023-02-28 | Fmc Corporation | Pyrrolidinones herbicides |
| KR102479858B1 (ko) | 2014-07-02 | 2022-12-21 | 에프엠씨 코포레이션 | 피페리디논계 제초제 |
| AU2015361018B2 (en) | 2014-12-08 | 2020-01-16 | Fmc Corporation | 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones |
| AU2016246410B2 (en) | 2015-04-10 | 2020-11-05 | Fmc Corporation | Substituted cyclic amides as herbicides |
| BR112017020094B1 (pt) | 2015-04-27 | 2022-01-11 | Fmc Corporation | Composto, composições herbicidas, mistura de herbicida e método para controlar o crescimento de vegetação indesejada |
| WO2016182780A1 (en) | 2015-05-12 | 2016-11-17 | E I Du Pont De Nemours And Company | Aryl substituted bicyclic compounds as herbicides |
| JP6869192B2 (ja) | 2015-05-29 | 2021-05-12 | エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ | 除草剤としての置換環状アミド |
| RU2017142979A (ru) | 2015-06-02 | 2019-07-15 | ЭфЭмСи Корпорейшн | Замещенные циклические амиды и их применение в качестве гербицидов |
| CA2993000C (en) | 2015-07-31 | 2024-01-23 | E.I. Du Pont De Nemours & Company | Cyclic n-carboxamide compounds useful as herbicides |
| AU2017378640B2 (en) | 2016-12-21 | 2022-03-03 | Fmc Corporation | Nitrone herbicides |
| JP7201609B2 (ja) | 2017-03-21 | 2023-01-10 | エフ エム シー コーポレーション | ピロリジノン及びこれらを調製するためのプロセス |
| WO2018175231A1 (en) | 2017-03-21 | 2018-09-27 | Fmc Corporation | Herbicidal mixture, composition and method |
| AR111967A1 (es) | 2017-05-30 | 2019-09-04 | Fmc Corp | Amidas herbicidas |
| AR111839A1 (es) | 2017-05-30 | 2019-08-21 | Fmc Corp | Lactamas 3-sustituidas herbicidas |
| GB201901559D0 (en) | 2019-02-05 | 2019-03-27 | Syngenta Crop Protection Ag | Herbicidal compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1309692A (en) * | 1970-02-13 | 1973-03-14 | Ucb Sa | N-substituted lactams |
| GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| BR0015974A (pt) * | 1999-12-01 | 2002-07-23 | Ucb Sa | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto |
| GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| WO2002067931A1 (en) * | 2001-02-23 | 2002-09-06 | Johns Hopkins University | Treatment of tics, tremors and related disorders |
-
2002
- 2002-10-07 CA CA002461961A patent/CA2461961A1/en not_active Abandoned
- 2002-10-07 HU HU0401667A patent/HUP0401667A2/hu unknown
- 2002-10-07 EP EP02774687A patent/EP1435943B1/de not_active Expired - Lifetime
- 2002-10-07 MX MXPA04002714A patent/MXPA04002714A/es not_active Application Discontinuation
- 2002-10-07 DE DE60218193T patent/DE60218193T2/de not_active Expired - Lifetime
- 2002-10-07 JP JP2003533931A patent/JP4351909B2/ja not_active Expired - Fee Related
- 2002-10-07 US US10/489,660 patent/US20040242671A1/en not_active Abandoned
- 2002-10-07 PL PL02370529A patent/PL370529A1/xx not_active Application Discontinuation
- 2002-10-07 AT AT02774687T patent/ATE353645T1/de not_active IP Right Cessation
- 2002-10-07 WO PCT/EP2002/011203 patent/WO2003030899A2/en not_active Ceased
- 2002-10-07 ES ES02774687T patent/ES2281545T3/es not_active Expired - Lifetime
- 2002-10-07 AU AU2002340971A patent/AU2002340971B2/en not_active Ceased
-
2007
- 2007-06-29 US US11/819,892 patent/US20080167366A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0401667A2 (hu) | 2004-12-28 |
| DE60218193D1 (de) | 2007-03-29 |
| MXPA04002714A (es) | 2004-07-05 |
| EP1435943A2 (de) | 2004-07-14 |
| JP2005504834A (ja) | 2005-02-17 |
| US20080167366A1 (en) | 2008-07-10 |
| AU2002340971B2 (en) | 2007-04-26 |
| CA2461961A1 (en) | 2003-04-17 |
| US20040242671A1 (en) | 2004-12-02 |
| JP4351909B2 (ja) | 2009-10-28 |
| DE60218193T2 (de) | 2007-11-22 |
| ES2281545T3 (es) | 2007-10-01 |
| WO2003030899A3 (en) | 2004-01-08 |
| EP1435943B1 (de) | 2007-02-14 |
| WO2003030899A2 (en) | 2003-04-17 |
| PL370529A1 (en) | 2005-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE353645T1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| ATE332702T1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| ATE268179T1 (de) | Verwendung von substituierten imidazo (1,2- a)pyridin-, -pyrimidin- und -pyrazin-3-yl-amin- derivaten zur herstellung von medikamenten zur nos-inhibierung | |
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE381537T1 (de) | Formanilid-derivative als beta2-adrenorezeptor- agonisten | |
| ATE213164T1 (de) | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids | |
| ATE219363T1 (de) | Lösliche prodrugs von paclitaxel | |
| MXPA05008617A (es) | Usos de anticuerpos anti-receptor del factor de crecimiento semejante a la insulina i. | |
| IL189546A0 (en) | Therapy for the treatment of disease | |
| SG166125A1 (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimeræs disease | |
| ATE451368T1 (de) | Azabicyclische verbindungen zur linderung von schmerzen und zur behandlung von erkrankungen des zentralen nervensystems | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
| ATE402710T1 (de) | Verwendung von 3-methoxy-pregnenolon bei der herstellung eines arzneimittels zur behandlung von neurodegenerativen erkrankungen | |
| DE60320579D1 (de) | Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen | |
| WO2005062992A3 (en) | Substituted melatonin derivatives, process for their preparation, and methods of use | |
| ATE311866T1 (de) | Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur | |
| ATE492285T1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
| ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
| IT1306184B1 (it) | Nitrilossi derivati della (r) e (s)-carnitina. | |
| DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| GEP20053512B (en) | S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders. | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |